In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) A...

FDA Device Recall #Z-1188-2024 — Class III — February 1, 2024

Recall Summary

Recall Number Z-1188-2024
Classification Class III — Low risk
Date Initiated February 1, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott Molecular, Inc.
Location Des Plaines, IL
Product Type Devices
Quantity 16 kits

Product Description

In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13q14.3) SpectrumOrange Probe, REF 01N34-020;

Reason for Recall

Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.

Distribution Pattern

US Nationwide distribution in the states of AL, CA, IL, MA, MD, MN, NY, and PA.

Lot / Code Information

(1) REF 01N15-010 - GTIN 00884999035362, Lot #381146, Exp. 2024-05-05; #381870, Exp. 2024-05-05; #382179 Exp. 2024-05-05; #387021, Exp. 2024-08-01; #528081, exp. 2023-11-16; (2) REF 01N34-020 - GTIN 00884999000766, Lot #522756, Exp. 2023-06-21.

Other Recalls from Abbott Molecular, Inc.

Recall # Classification Product Date
Z-1749-2025 Class II Alinity m Resp-4-Plex AMP Kit, List Number 09N7... Apr 28, 2025
Z-1748-2025 Class II Alinity m Resp-4-Plex Amplification (AMP) Kit (... Apr 28, 2025
Z-1665-2025 Class II The Alinity m System is designed to automate th... Mar 20, 2025
Z-0233-2025 Class II Abbott Alinity m HPV AMP Kit, used with the Ali... Sep 12, 2024
Z-0234-2025 Class II Abbott Alinity m STI AMP Kit, used with the Ali... Sep 12, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.